Drugs Archives - Page 7 of 65

American Health Under Trump — Past, Present, and Future

Episode 364

Sept. 19, 2024

Dreaming of a Trump victory, Republicans have a wish list of health policy changes — including loosening Affordable Care Act regulations to make cheaper coverage available and ending Medicare drug price negotiations. Meanwhile, after a publicly reported death stemming from a state abortion ban, Vice President Kamala Harris is emphasizing the consequences of Trump’s work to overturn Roe v. Wade. Tami Luhby of CNN, Shefali Luthra of The 19th, and Joanne Kenen of Politico and Johns Hopkins University join KFF Health News senior editor Emmarie Huetteman to discuss these stories and more.

Listen Now

A roll of one hundred dollar bills sits among a row of prescription medication bottles.

California May Regulate and Restrict Pharmaceutical Brokers

California lawmakers are moving to rein in the pharmaceutical middlemen they say drive up costs and limit consumers’ choices. The bill sent to Gov. Gavin Newsom would require pharmacy benefit managers to be licensed in California and would ban some business practices. Newsom vetoed a previous effort three years ago.

By Don Thompson

Sept. 18, 2024

Health Brief

Harris and Trump Are Ready To Take on Big Pharma

By Stephanie Armour

Sept. 10, 2024

A hand is holding a remote control, there is a blurred TV screen in the background.

Perspective

With TV Drug Ads, What You See Is Not Necessarily What You Get

The pharmaceutical industry has invented a new art form: finding ways to make their wares seem like joyous must-have treatments, while often minimizing lackluster efficacy and risks.

By Elisabeth Rosenthal

Sept. 9, 2024

Two photos shown next to each other: a photo of Donald Trump on the left and Kamala Harris on the right.

Elections

For Pharma, Trump vs. Harris Is a Showdown Between Two Industry Foes

Vice President Kamala Harris is seen as more aggressive than former President Donald Trump in taking on pharmaceutical companies, but Trump allies say he would also make lowering drug costs a top priority.

By Stephanie Armour

Aug. 26, 2024

How Little Denmark Got Homegrown Giant Novo Nordisk To Lower Ozempic Prices

As Congress pushes for Medicare to cover payment for anti-obesity drugs, Denmark — Ozempic maker Novo Nordisk’s home — has limited coverage of the drug after cost overruns “emptied all the money boxes in the entire public health system.”

By Arthur Allen

Aug. 8, 2024

A person holds a box of mifepristone in their hands.

Since Fall of ‘Roe,’ Self-Managed Abortions Have Increased

The percentage of people who say they’ve tried to end a pregnancy without medical assistance increased after "Roe v. Wade" was overturned. One of the most common reasons for seeking a self-managed abortion was privacy concerns.

By Sarah Varney

Aug. 2, 2024

Health Brief

Copycat Weight-Loss Drugs Are Major Players With Consumers

By Arthur Allen

July 31, 2024

What the Health? From KFF Health News

Harris in the Spotlight

Episode 357

July 25, 2024

For the 2024 campaign, Joe Biden is out, and Kamala Harris is in. As the vice president makes moves toward the top of the Democratic presidential ticket, health policy is resurging as a campaign issue. Meanwhile, Congress tries — and again fails — to make timely progress on the annual government spending bills as abortion issues cause delays. Alice Miranda Ollstein of Politico, Stephanie Armour of KFF Health News, and Rachel Cohrs Zhang of Stat join KFF Health News’ Julie Rovner to discuss these issues and more. Also this week, Rovner interviews Anthony Wright, the new executive director of Families USA, about his plans for the organization and his history working with Harris on health topics. 

Listen Now

A photo of the exterior of Wall Drug's complex.

Postcard From South Dakota

World-Famous Wall Drug Isn’t Immune From Challenges Facing Rural Pharmacies

Even as part of a popular South Dakota tourist attraction, an independent pharmacy serving locals, remote ranchers, and sightseers struggles with staffing and insurer payments.

By Arielle Zionts

July 24, 2024

A photo of boxes of mifepristone and next to a pill bottle of misoprostol.

Louisiana Reclassifies Drugs Used in Abortions as Controlled Dangerous Substances

Louisiana lawmakers have added two drugs commonly used in pregnancy and reproductive health care to the state’s list of controlled dangerous substances, a move that has alarmed doctors in the state.

By Rosemary Westwood, WWNO

July 24, 2024

An illustration drawn with pencil and colored digitally shows a scientist-type man in the center of the image. He holds two halves of an Ozempic-like injector in his gloved hands and pours a mysterious liquid from one side to the other. Behind him, corporate copycats, drawn as floating heads and hands, watch to steal his formula while they manipulate their own mysterious liquid. The floating copycats repeat into the background.

Why Millions Are Trying FDA-Authorized Alternatives to Big Pharma’s Weight Loss Drugs

Although Novo Nordisk and Lilly lump together the pharmacies that compound semaglutide and tirzepatide with internet cowboys selling fake drugs, there is a distinction. The FDA has offered Americans little clarity about the vast gray and black markets for the drugs.

By Arthur Allen

July 23, 2024

A photo of Kamala Harris on a stage in front of a podium with a microphone.

Elections

Harris, Once Biden’s Voice on Abortion, Would Take an Outspoken Approach to Health

If she grabs the baton from President Joe Biden to become the new presumptive Democratic presidential nominee, Kamala Harris would widely be expected to take an aggressive stance in support of abortion access — hitting former President Donald Trump on an issue that could undermine his chances of victory.

By Stephanie Armour, Julie Appleby, and Julie Rovner

July 21, 2024

A photo of the Supreme Court's exterior at sunrise.

The Supreme Court Just Limited Federal Power. Health Care Is Feeling the Shockwaves.

A Supreme Court ruling restricting federal power will likely have seismic ramifications for health policy. A flood of litigation — with plaintiffs like small businesses, drugmakers, and hospitals challenging regulations they say are too expensive or burdensome and not authorized by law — could leave the country with a patchwork of disparate health regulations.

By Stephanie Armour

July 1, 2024

1st Biden-Trump Debate of 2024: What They Got Wrong, and Right

A debate marked by President Joe Biden’s faltering performance featured clashes over insulin costs, inflation, abortion, immigration, and Jan. 6.

By KFF Health News and PolitiFact staffs

June 28, 2024

What the Health? From KFF Health News

SCOTUS Rejects Abortion Pill Challenge — For Now

Episode 351

June 13, 2024

The Supreme Court has dismissed a challenge to the FDA’s approval of the abortion pill mifepristone, ruling unanimously that the anti-abortion doctor group that filed the suit lacked standing. But abortion opponents are expected to pursue other strategies to ban or restrict the medication. Meanwhile, the Biden administration moves to stop the inclusion of medical debt on individual credit reports, and former President Donald Trump tries to claim credit for $35 insulin. Anna Edney of Bloomberg News, Rachana Pradhan of KFF Health News, and Emmarie Huetteman of KFF Health News join KFF Health News chief Washington correspondent Julie Rovner to discuss these stories and more. Also this week, Rovner interviews KFF president and CEO Drew Altman about KFF’s new “Health Policy 101” primer.

Listen Now

Vertical images of three men, side by side. the first poses for the camera wearing a shirt and tie; second wearing a blue polo and smiling in front of shelves of prescriptions; third wearing a white coat and glasses, smiling in front of shelves of prescriptions.

Biden Plan To Save Medicare Patients Money on Drugs Risks Empty Shelves, Pharmacists Say

President Joe Biden is campaigning for reelection on his efforts to cut costs for Medicare patients at the pharmacy counter. But independent pharmacists say one strategy makes it unaffordable for them to keep some brand-name medicines in stock.

By Susan Jaffe

June 11, 2024

Health Brief

Weight-Loss Drugs Are So Popular They’re Headed for Medicare Negotiations

By Renuka Rayasam

June 7, 2024

Letters to the Editor

Readers Issue Rx for Clogged ERs and Outrageous Out-of-Pocket Costs

KFF Health News gives readers a chance to comment on a recent batch of stories.

June 3, 2024

KFF Health News On Air

Journalists Talk Cost of Weight Loss Drugs and Lack of Obesity Doctors to Manage Their Use

KFF Health News and California Healthline staff made the rounds on national and local media this week to discuss topical stories. Here’s a collection of their appearances.

June 1, 2024

Trump 2.0

Public Health

Audio Reports

Special Reports

More Topics

Drugs